# The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency

> **NCT06883656** · PHASE1 · COMPLETED · sponsor: **Shenzhen Salubris Pharmaceuticals Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)
- Renal Insuficiency

## Interventions

- **DRUG:** SAL067

## Key facts

- **NCT ID:** NCT06883656
- **Lead sponsor:** Shenzhen Salubris Pharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06883656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06883656, "The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06883656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*